Objectives: Treatment options for venous insufficiency are rapidly evolving in the office setting and include venography, intravascular ultrasound, and venous stenting. Non-thrombotic iliac vein lesions assessment and treatment in an office setting is currently an area of interest. The purpose of this study is to demonstrate the safety and efficacy of evaluating non-thrombotic iliac vein lesion with this office-based procedure in octogenarians and nonagenarians. Methods: From January 2012 through December 2013, 300 non-thrombotic iliac vein lesion limbs in 192 patients with venous insufficiency !80 years old were evaluated for non-thrombotic iliac vein lesion. Patients were evaluated and treated with venography, intravascular ultrasound, and stent placement for significant lesions demonstrated by greater than 50% diameter or cross-sectional area reduction. Group 1: 168 of these patients were octogenarians; female/male ratio was 1.75:1, bilateral in 89/168 patients (53%), left sided in 131/259 limbs (51%), right sided in 128 limbs (49%), average age 83.5 AE 2.6 years (range 80-89) compared to Group 2: 24 nonagenarians; female/male was 3:1, bilateral in 17/24 patients (70%), left sided in 20/41 limbs (49%), right sided in 21/41 limbs (51%), average age 92.9 AE 2.2 years (range 90-99). Stent related outcomes were evaluated with communication to the patient within 24 h to assess post-procedure pain followed by serial iliocaval ultrasonography. Results: Out of the 300 limbs evaluated, in Group 1, 86% of limbs had stents placed compared to 90% in Group 2 and 11% of both groups had two stents placed. Overall improvement in pain, edema, and ulcers was reported in 147 (59%) of octogenarians and 24 (65%) of nonagenarians. There were no surgical site infections, pseudo-aneurysms, arteriovenous fistulas, or femoral artery injuries. No patients required transfusion within three days post-operatively and there were no 30-day mortalities in both sets of patients.
Introduction
Iliac vein compression syndrome has been demonstrated on post-mortem exams to be prevalent in 22-33% of autopsy series. 1 The contribution of spurs or webs to the development of lower extremity symptoms was first described by McMurrich in 1908. 2 May-Thurner syndrome was described 50 years later in 1957. 3 At that time, they postulated that the extrinsic pulsatility of the right iliac artery produced changes on the left iliac vein. The clinical features of this pathophysiology were described first by Cockett and Thomas in 1965.
Typical treatment for venous insufficiency in our practice is plagued by noncompliance, inability to use the stockings. For these patients, endovenous ablations have shown excellent results. In addition, we also offer iliac vein evaluation to ameliorate their venous symptoms when other methods have failed. The contribution of iliac vein compression by Raju in 2006 has been shown to have a permissive role in pathogenicity. In this present series, due to the excellent results from the prior literature, interrogation of the iliac veins after correction of infrainguinal reflux failed to provide relief was attempted.
With an aging population, the impetus for intervention may be lessened because of the increased fragility in the elderly population. As techniques improve, evaluation and treatment of iliac vein stenosis continues to evolve with time. Contrary to previous beliefs that venoplasties are optimally performed in a hospital setting where ancillary staff are available should issues arise, our experience with office-based venoplasties has been otherwise. Due to the perceived increased risk, some have questioned the safety and efficacy of iliac vein stenting in the elderly. The goals of this study are to share our office-based experience in these elderly patients in whom iliac vein stenting was performed.
Methods
From January 2012 through December 2013, 300 limbs from 192 octogenarians and nonagenarians presented with leg pain, edema, or ulcers. These patients were evaluated and treated in our office which is fully accredited by New York State and the American Association for Accreditation of Ambulatory Surgery Facilities (AAAASF). Initial diagnostic evaluation consisted of bilateral lower extremity venous mapping, ultrasound evaluation of the inferior vena cava and iliac veins. Once the patients have failed standard compression therapy after three months and endovenous therapy for infrainguinal reflux, they were planned for iliac venography, intravascular ultrasound (IVUS), and possible stent insertion.
Patients who had a history of sensitivity or anaphylaxis to intravenous contrast administration were excluded from this study. Morbidly obese patients weighing over 350 pounds were excluded due to weight limitation of the operating room table. Those who could not lay flat due to spinal stenosis or other pathology were excluded. In addition, psychiatric patients who were unable to cooperate, severe chronic obstructive pulmonary disease, or American Society of Anesthesiologists (ASA) IV were excluded.
The diagnosis of obstruction, indications for iliac vein stenting, and technical details of stenting have been previously described. [4] [5] [6] [7] [8] [9] Routinely, the patients were given 5 mg of diazepam 1 h before the start of the procedure. The patients sign an informed consent and the patients were placed supine on the fluoroscopy compatible operating table.
Access was obtained in the femoral vein. We used ultrasound to administer peri-adventitial local anesthetic to lessen pain when upsizing and inserting sheaths. Procedure start time and end time were measured from skin puncture to removal of the sheath, respectively. Once access is obtained with a 4Fr microsheath, it is exchanged for a 10Fr sheath which allows passage of both diagnostic IVUS and therapeutic stents. Heparinized saline is intermittently flushed through the sheath during the procedure replacing systemic heparinization. No antibiotics are administered during the procedure. Patients are explained prior to balloon inflation that they may experience some discomfort. No antibiotics were given to the patients, even if they had venous ulcers.
Transcutaneous duplex performed prior to the IVUS did not demonstrate outflow obstruction in the iliac veins since it is not a sensitive enough technique as compared to IVUS. After venography, IVUS is performed. There are instances where one may see a false-negative venogram, where no stenosis is visible as seen in Figure 1 . In these cases, the area of stenosis is, however, clearly visible on IVUS as seen in Figure 2 . The cross-sectional area of the compressed vein is compared to the area of the normal vein distal to the stenosis using IVUS. Areas of >50% cross-sectional area or diameter reduction are treated with stent placement with the aid of flouroscopy. We use 16 mm to 20 mm Wallstents (Boston Scientific, Natick, MA) to stent the stenotic area. The stent underwent balloon angioplasty and IVUS is repeated to ensure the maximal stenosis has been adequately treated. Finally, a completion venogram and IVUS are performed to ensure treatment success, and also to document adequate position of the stent.
The delivery system is then removed, the patient is placed in Trendelenburg position, and manual compression is held until hemostasis is achieved. The patients are then held in the recovery room for 1 h and discharged to home.
In the recovery room, a pain score was recorded according to the visual analogue scale (VAS) from 0 to 10, wherein 10 is the most severe pain. 8 VAS was used on initial evaluation but not on subsequent evaluations of pain because the patients had insignificant post-op pain after the first visit. Clinical follow-up and duplex interrogation was at one week, one month, three months, and then every three months thereafter. After one year of documented stent patency the stent ultrasound investigation was changed to annually. Clopidogrel 75 mg was given daily for 90 days for patients not on any anticoagulants. Any patient who had lower extremity ulceration was followed weekly until the ulcer healed. Patients were asked on followup if they had either improvement, no change, or worsening of pain, pain and edema, or edema.
Institutional review board from Total Vascular Care approved this retrospective study, and provided us a waiver for informed consent. All patients were accounted for during the study period and patient demographics were kept according to the principles established by the Declaration of Helsinki.
Individual data are given as median with range or mean standard deviation (SD), unless otherwise indicated. Continuous variables were analyzed by t test or nonparametric Wilcoxon rank test for paired and unpaired data, depending on skewness, and the Fisher exact test for categorical variables, using the program IBM SPSS Statistics 22 for the statistical analysis. Cumulative survival analysis was also used to analyze and compare recurrence of pain, swelling, and ulcer after the treatment.
Results
After collecting data on patients, we have been able to keep procedure time to an average of 15 min (range 9-31 min). Radiation exposure is also kept to an absolute minimum with an average exposure time of 1.18 min (range 0.5-6.3 min).
In the octogenarian group, 222/259 (86%) of the limbs had iliac vein stents placed and 24/222 (11%) had two stents placed. For the nonagenarians, 37/41 (90%) of the limbs had stents placed and 4/37 (11%) had two stents placed. The average pain based on the VAS was 1.11 AE 2.1 and 0.57 AE 1.54; p ¼ 0.11, in Groups 1 and 2, respectively. Table 1 illustrates the relationship between Clinical, Etiology, Anatomy, and Pathophysiology (CEAP) scores and patient outcomes (pain, edema, pain þ edema, ulcer healing). Table 2 illustrates where the stents were placed.
On follow-up, 192 patients were evaluated on an average of 57 AE 23 weeks (range 1-126 weeks). Ten patients (5.2%) were lost to follow-up (two nonagenarians and eight octogenarians).
Of the 251/259 limb procedures in the octogenarians who followed up, 147 (59%) reported improved pain, Figure 2 . A positive IVUS test, in the same patient as in Figure 1 , demonstrating visible stenosis in the mid-common iliac vein. edema, pain þ edema, and ulcer healing, 88 (35%) reported no change, and 15 (6%) reported worsening. Of the 37/41 limb procedures in the nonagenarians who followed up, 24 (65%) reported improved pain, edema, pain þ edema, and ulcer healing, 11 (30%) reported no change, and 2 (5%) reported worsening. It should be noted that 100% of the nonagenarians' ulcers healed after iliac vein stenting. The patients who reported a worsening of symptoms were evaluated with transcutaneous duplex for stent patency. These patients were not considered as part of the successful treatment group. Tables 3 and 4 demonstrate these results. The patients had no short-term post-op complications, or change of status to inpatient admission and no post-op infectious complications. Technical success was 100%. Every occluded iliac vein was picked up by transcutaneous duplex. All the lesions in this dataset found were non-thrombotic. All stents were patent upon examination with transcutaneous duplex. No stent fractures were noted on fluoroscopy/ultrasound (US), but no routine X-rays were done to evaluate stent fractures.
Discussion
Stenting of the iliac veins for non-thrombotic iliac vein lesions (NIVLs) in octogenarians and nonagenarians can be performed with very low risk and excellent mid-term patency. The clinical efficacy was very high and resulted in major symptom relief in the majority of patients. Leg swelling in elderly patients is often thought to be due to cardiac causes, hormonal imbalance, or fluid imbalance. These data suggest further consideration of other causes such as venous insufficiency and iliac venous compression. 10 There is a reluctance to apply this technology in the elderly. Since this is a new technology and most of the data have not been focused on the elderly, our effort was to hone in on this sector. We chose patients by their functional status rather than by a specific set of criteria. Patients are placed under local anesthesia rather than general anesthesia since general anesthesia carries higher risks for the elderly population. As previously discussed by Raju and Ward, 11 iliac vein stenting in octogenarians and nonagenarians is safe when compression therapy fails or is not possible.
The exquisite detail and resolution of 0.1 mm of IVUS allows accurate assessment of NIVLs. As previously described by Negus et al., 12 venographic data obtained in these patients have a poor diagnostic utility and IVUS should be the gold standard in identification of NIVLs. Thus, we routinely rely on IVUS's role in demonstrating the stenosis with a diagnostic sensitivity greater than 90% according to Negle´n and Raju, 5 Not only does IVUS provide is an indispensable aid to identify the presence of these lesions but it also directs us for proper stent placement and post-stent evaluation and efficacy.
Octogenarians and nonagenarians represent the fastest growing sector of the population today. Esses et al. 13 have identified several preoperative variables including age (>70 years), body mass index (<18.5 kg/m 2 ), anemia (hematocrit <35%), history of stroke, hypoalbuminemia (<3.5 g/dL), partially or totally dependent functional status. These factors have not been extrapolated to other procedures; however, in this present series with the very low periprocedural risk and excellent mid-term outcome, it would be doubtful that these risk factors would significantly impact this cohort.
Urman and Shapiro 14 have categorized the shift of health care delivery from the hospital to the officebased setting as the "wild wild west" of medicine. Despite this claim, office-based procedures have continued to spread at a rapid pace and it has been estimated that over 12 million procedures have been performed in 2009 alone. This has been a direct result of decreasing inpatient reimbursement and growing consumer demand. Office-based procedures can pose significant cost savings while maintaining safety and efficacy. As the health care demand continues to increase, the need will be met by increasing the supply. In our patient population, we attribute our safety profile to a number of factors. Meticulous attention to detail and patient cooperation is a must to ensure this procedure can be done safely.
The beneficial clinical outcome in our present series has been reflected by the success Neglen et al. 1 have had with their recent series of 982 stents. In their series, they had a modest 1.5% thrombotic rate. However, in their series the median age was 54 years old and their oldest patient was 90 years old. Their series is one of the largest reported sets of patients in which they reported a beneficial clinical outcome regardless of remaining reflux, adjunct saphenous procedures, or etiology of obstruction. Some weaknesses in this study that open up the possibility of biases are: this was a retrospective study, it was conducted at only one office location, and the patient cohort was made up of a selected population of patients, and no data is included for long-term outcomes. Some additional factors to look in future studies include: the relationship with body mass indexes, or the role of infrainguinal superficial and deep venous insufficiency and whether there are differences in the outcome with respect to age with larger datasets. These questions warrant further study to determine if they would influence the outcome of iliac vein stenting therapy.
Conclusion
Iliac vein stenting for NIVLs in octogenarians and nonagenarians may be safely performed in an officebased setting. Venography, IVUS are minimally invasive modalities that carry little risk when performed in selected patients. In conclusion, we believe that the treatment of NIVL in an office-based setting is safe and efficacious in both octogenarians and nonagenarians and is an attractive alternative to hospital-based intervention.
